KTTA
Income statement / Annual
Last year (2023), Pasithea Therapeutics Corp.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Pasithea Therapeutics Corp.'s net income was -$15.96 M.
See Pasithea Therapeutics Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$486,559.00
|
$15,062.00
|
$0.00
|
| Cost of Revenue |
$648,454.00 |
$113,195.00 |
$17,275.00 |
$0.00 |
| Gross Profit |
-$648,454.00 |
$373,364.00 |
-$2,213.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0.77 |
-0.15 |
0 |
| Research and Development
Expenses |
$8.10 M
|
$2.67 M
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$7.88 B
|
$9.92 M
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
-$7.87 B
|
$2.60 M
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$7.88 M
|
$12.52 M
|
$4.51 M
|
$40,984.00
|
| Other Expenses |
$0.00 |
$44,723.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$15.98 M |
$15.19 M |
$4.51 M |
$40,984.00 |
| Cost And Expenses |
$15.98 M |
$15.30 M |
$4.52 M |
$40,984.00 |
| Interest Income |
$0.00 |
$102.00 |
$508.00 |
$0.00 |
| Interest Expense |
$0.00 |
$102.00 |
$508.00 |
$0.00 |
| Depreciation &
Amortization |
$648,454.00
|
$5,094.00
|
$1,379.00
|
$61,476.00
|
| EBITDA |
-$15.33 M
|
-$14.74 M
|
-$4.51 M
|
-$40,980.00
|
| EBITDA Ratio |
0 |
-30.29 |
-299.17 |
0 |
| Operating Income Ratio
|
0
|
-30.45
|
-299.26
|
0
|
| Total Other
Income/Expenses Net |
$471,613.00
|
$879,869.00
|
$2.33 M
|
-$4.00
|
| Income Before Tax |
-$15.51 M |
-$13.94 M |
-$2.17 M |
-$40,984.00 |
| Income Before Tax Ratio
|
0
|
-28.64
|
-144.3
|
0
|
| Income Tax Expense |
$453.91 M |
-$879,971.00 |
$508.00 |
-$61,476.00 |
| Net Income |
-$15.96 M |
-$13.06 M |
-$2.17 M |
-$40,984.00 |
| Net Income Ratio |
0 |
-26.83 |
-144.34 |
0 |
| EPS |
-12.65 |
-10.34 |
-1.89 |
-0.0595 |
| EPS Diluted |
-13.01 |
-10.34 |
-1.89 |
-0.0595 |
| Weighted Average Shares
Out |
$1.26 M
|
$1.26 M
|
$1.15 M
|
$688,918.00
|
| Weighted Average Shares
Out Diluted |
$1.23 M
|
$1.26 M
|
$1.15 M
|
$688,918.00
|
| Link |
|
|
|
|
